Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer

by Theodore Gourdin, Guru Sonpavde
Published 2018-01-01

265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort

by Luc Dirix, Frank Beier, Alain Ravaud, Theodore Gourdin, Jean-Laurent Deville, Marco Maruzzo, XiaoZhe Wang, Yulia Vugmeyster, Jeorg Seebeck, Sarah Chennoufi
Published 2020-11-01

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis

by Keun-Wook Lee, Luc Dirix, Andrea B Apolo, John A Ellerton, Manish Agrawal, Michael S Gordon, Raid Aljumaily, Theodore Gourdin, Matthew H Taylor, Juliane Manitz, Gregory Pennock
Published 2020-07-01